Pre-Commercial Procurement to Buy R&D (Research and Development) Services to Deliver... Tender

FUNDACIÓN DE GESTIÓN SANITARIA DEL HOSPITAL DE LA SANTA CREU I SANT PAU has floated a tender for Pre-Commercial Procurement to Buy R&D (Research and Development) Services to Deliver Quick Responses for Individuals with Advanced Heart Failure and Complex Care Needs through Integrated Care (Tique). The project location is Spain and the tender is closing on 23 Jul 2022. The tender notice number is 374082-2021, while the TOT Ref Number is 55483198. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : Spain

Summary : Pre-Commercial Procurement to Buy R&D (Research and Development) Services to Deliver Quick Responses for Individuals with Advanced Heart Failure and Complex Care Needs through Integrated Care (Tique)

Deadline : 23 Jul 2022

Other Information

Notice Type : Tender

TOT Ref.No.: 55483198

Document Ref. No. : 374082-2021

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : EUR 3498969.25

Purchaser's Detail

Purchaser : FUNDACIÓN DE GESTIÓN SANITARIA DEL HOSPITAL DE LA SANTA CREU I SANT PAU
Address : 167 — Pabellón Sant Antoni planta baja
Town : Barcelona
NUTS-Code : SE331 - Västerbottens län
Postal Code : 08025
Contact Point : Unidad de Contratación
Phone : +34 935537621
Fax : +34 935537631
Spain
Email :contractacions@santpau.cat
URL :www.santpau.cat

Tender Details

Document Type : Prior information notice without call for competition

Title : Pre-Commercial Procurement to Buy R&D (Research and Development) Services to Deliver Quick Responses for Individuals with Advanced Heart Failure and Complex Care Needs Through Integrated Care (TIQUE)

Reference Number : 2021/S 141-374082

Contract Type : Services

Estimated Value : 3498969.25 - EUR

Description : This PIN provides early information about the expected starting date and purchase volume for a pre-commercial procurement (PCP) and about the open market consultation (OMC) that is organised in preparation of this procurement. See sections II.2.4) and II.2.14) for details.

The procurement aims to trigger new solutions to be developed and tested to address the following challenge: improve treatment for patients with advanced heart failure and complex care needs through technology enabled integrated care solutions.

The main target improvements are:

• 33 % increase of patient life expectancy;

• 40 % reduction of acute hospital admission;

• 20 % reduction of drug-related health problems;

• 20 % increase of home care attention; and

• 10 % increase of end-of-life care at home.

This PCP procurement is a joint procurement by different procurers across Europe that are all facing the same common challenge and are thus looking for similar solutions (so-called ‘buyers group-).



73100000 - Research and experimental development services

32441100...

Documents

 Tender Notice